novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Clinical presentation and diagnosis of myocarditis

16 Fevereiro 2016

doi: 10.1136/heartjnl-2014-306363

doi: 10.1136/heartjnl-2014-306363

doi: 10.1136/heartjnl-2014-306363

Tags:
Novidades científicas

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

16 Fevereiro 2016
0

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

16 Fevereiro 2016
0

-->